Delivery Order SPE2DB24D6039-SPE2DB25FLENN
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,119.97 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (100-count) on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $5,680.22 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $8,787 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award from the agency's Medical Supply Chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,528.93 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with an ultimate completion date of July 24, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 100 units under a firm fixed-price contract. The award, valued at $2,591.90, was competitively awarded without set-aside designation and reflects a completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,119.60 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets in unit dose packaging containing 100 tablets. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. The order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- This is a $3,689.15 firm-fixed-price delivery order awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,568,494,137 units of the drug Cetirizine HCL 5 mg Tablet in 100-count bottles. The delivery order has an ultimate completion date of June 10, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.64 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in unit dose packaging (100 count). This contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,491.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine Hydrochloride 5 mg tablets. The contract has a ceiling value of $16,241.24 and is a firm fixed price award without a set-aside designation, indicating open competition. The ultimate completion date is June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D6039Indefinite Delivery Contract
- SPE2DB24D6039-SPE2DB25FLENNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order exemplifies the company's role as a primary pharmaceutical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/10/25 |